Connectmedica is pleased to announce that Bristol Myers Squibb, a global biopharmaceutical company, has decided to extend and continue the use of the Highp next-generation video communication platform in the Middle East and North Africa (MENA) region. This decision reaffirms the company's commitment to leveraging innovative technologies for improved communication and stakeholder engagement.
Bristol Myers Squibb has a strong presence in the United Arab Emirates (UAE), where they have been operating for more than two decades. In the UAE, Bristol Myers Squibb focuses on research and development, manufacturing, and distribution of innovative medicines across various therapeutic areas. The company's dedication to addressing unmet medical needs has made them a leader in the healthcare industry in the region.
Bristol Myers Squibb has chosen to use Highp video messaging to enhance direct communication with all stakeholders, including those who cannot be visited in person. This decision reflects the company's understanding of the critical role that effective communication plays in maintaining strong relationships with partners, customers, and healthcare professionals.
Highp's video communication platform offers several key benefits, including:
- Strengthened relationships: Highp's personalized video messages enable Bristol Myers Squibb to maintain and deepen connections with stakeholders, even when in-person visits are not possible.
- Enhanced engagement: By using Highp's interactive video messaging, Bristol Myers Squibb can provide stakeholders with relevant, engaging, and timely content tailored to their needs and preferences.
- Improved collaboration: The Highp platform facilitates seamless communication among various stakeholders, fostering collaboration and improving overall productivity and efficiency.
The importance of nurturing relationships through video communication cannot be understated, as it allows for more personal and genuine connections. Highp's video messaging platform enables Bristol Myers Squibb to convey complex information in an easy-to-understand format while demonstrating the company's dedication to transparency, innovation, and customer satisfaction.
Connectmedica is proud to be working with Bristol Myers Squibb in the MENA region, and we are committed to supporting their efforts to enhance communication and strengthen relationships with all stakeholders. The continued investment in Highp by a leading global biopharmaceutical company such as Bristol Myers Squibb is a testament to the platform's effectiveness and value in the healthcare industry.